Skip to content
  • Home
  • Company
    • About Us
    • Departments
    • Message From MD
  • Product
    • General
    • Hormones
    • Urology
    • Steroids
  • Media
    • Insights
    • Blogs
    • Gallery
  • Careers
  • Contact Us
Menu
Home / Urology / Benign Prostatic Hyperplasia Agents / MILAGE
Benign Prostatic Hyperplasia Agents

MILAGE

Tadalafil is a phosphodiesterase 5 inhibitor used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension.

QR Code

General Info

COMPOSITION:

Milage 5
Each film coated tablet contains
Tadalafil 5 mg

Milage 10
Each film coated tablet contains
Tadalafil 10 mg

Milage 20
Each film coated tablet contains
Tadalafil 20 mg

DOSAGE FORM:

Tablets

PHARMACOLOGICAL CATEGORY:

Phosphodiesterase type 5 inhibitor (cGMP-specific)

THERAPEUTIC CATEGORY:

Urologicals, Drugs used in erectile dysfunction

INDICATIONS AND DOSAGE REGIMEN:

MILAGE 5
For the treatment of erectile dysfunction in adult males (daily use), taken once a day at the same time each day.
To treat the signs and symptoms of Benign Prostatic Hyperplasia (BPH) taken once a day at the same time each day.

MILAGE 10
Treatment of erectile dysfunction in adult males (as needed), no more than once a day, taken 30 minutes before you think sexual activity may occur.

MILAGE 20
Treatment of pulmonary arterial hypertension (PAH) classified as WHO functional class II and III, to improve exercise capacity in adults. Two tablets taken at the same time each day. The doctor may adjust the dose as needed.

The dose must be as directed by the physician. It is recommended to be taken with or without food.

This medication should not be used in children as safety and efficacy has not been established.

METHOD OF ADMINISTRATION:

Route of Administration: Oral

PREGNANCY AND LACTATION:

Not recommended for use in pregnant and lactating women.

STORAGE AND HANDLING:

Keep the medication stored at normal room temperature and out of reach of children.

Dispose unused medications and expired medications properly to avoid adverse effects.

Related Products

PROSFLO
  • BPH symptom relief
  • Aids passage of ureteral stones
  • Symptomatic relief in prostatitis
  • Improves urinary flow (including in females)

Benign Prostatic Hyperplasia Agents

PROSFLO

PROSTIF
  • Benign prostatic hyperplasia (BPH)
  • Symptom relief in enlarged prostate
  • Reduces risk of acute urinary retention
  • Decreases need for BPH surgery

Benign Prostatic Hyperplasia Agents

PROSTIF

PROS-D
  • BPH symptom relief
  • Reduces risk of AUR
  • Delays/avoids BPH surgery
  • Can be combined with Tamsulosin

Benign Prostatic Hyperplasia Agents

PROS-D

UROXATE
  • Urinary frequency & incontinence
  • Dysuria & urinary urgency
  • Nocturia
  • Bladder spasms (post-catheter/procedures)
  • Cystitis & related urinary tract inflammation

Urinary Tract Spasmolytic

UROXATE

OHM Insights

View Detail

OHM INSIGHT 24th issue

View Detail

OHM INSIGHT 23nd Issue

View Detail

OHM INSIGHTS- 22th Issue

View Detail

OHM INSIGHT 21st ISSUE

OPL believes in developing medicines and products that are cost-effective as well are capable of providing high quality care to improve the health of the patients.

Quick Links
  • About Us
  • Contact Us
  • Products
  • Dealer Locator
  • Blogs
  • Our Team
  • Career
Product Category
  • General
  • Urology
  • Steroids
  • Hormones
Corporate Office
(+977) 4110791, 01-4110761
info@opl.com.np
Babu Ram Acharya Marg, Sinamangal, Kathmandu
Factory Office
(+977) 4110791, 01-4110761
info@opl.com.np
Tathali-09, Bhaktapur

Copyright 2026 OHM Pharmaceuticals Lab Pvt. Ltd. All Rights Reserved

Website Designed & Developed by Theme Nepal